Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism

Overview

Journal Curr Treat Options Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2021 May 17

PMID 33994774

Citations 5

Authors

Maninder Singh

Irfan Shafi

Parth Rali

Joseph Panaro

Vladimir Lakhter

Riyaz Bashir

Affiliations

Soon will be listed here.

Abstract

Introduction: Acute pulmonary embolism (PE) remains an important cause of cardiovascular mortality and morbidity in the USA and worldwide. Catheter-based therapies are emerging as a new armamentarium for improving outcomes in these patients.

Purpose Of Review: The purpose of this review is to familiarize the clinicians with (1) various types of catheter-based modalities available for patients with acute PE, (2) advantages, disadvantages, and appropriate patient selection for the use of these devices, and (3) evidence base and the relevance of such therapies in the COVID-19 pandemic.

Recent Findings: There are four main types of catheter-based therapies in acute PE: (1) standard catheter-directed thrombolysis (CDT), (2) ultrasound-assisted CDT, (3) pharmacomechanical CDT, and (4) mechanical thrombectomy without thrombolysis. Ultrasound-assisted thrombolysis is the most widely studied modality in this group; however, evidence base for other catheter-based technologies is rapidly emerging.

Summary: Current use of catheter-based therapies is most suitable for patients with intermediate and high-risk acute PE. The adoption of a multidisciplinary approach like the pulmonary embolism response team (PERT) is desirable for appropriate patient selection and possibly/potentially improving patient outcomes. We discuss the current status of these therapies.

Citing Articles

Evidence-Based Anticoagulation Choice for Acute Pulmonary Embolism.

Maughan B, Kabrhel C, Jarman A JAMA Netw Open. 2025; 8(1):e2452850.

PMID: 39752164 PMC: 11805341. DOI: 10.1001/jamanetworkopen.2024.52850.

Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism.

Lyhne M, Bikdeli B, Jimenez D, Kabrhel C, Dudzinski D, Moises J Eur Heart J Acute Cardiovasc Care. 2024; 13(12):817-825.

PMID: 39442929 PMC: 11666307. DOI: 10.1093/ehjacc/zuae120.

Breaking Down Barriers in Pursuit of Thrombolytic Perfection.

Brailovsky Y, Ullah W JACC Adv. 2024; 2(9):100673.

PMID: 38938705 PMC: 11198677. DOI: 10.1016/j.jacadv.2023.100673.

Intermediate-Risk and High-Risk Pulmonary Embolism: Recognition and Management: Cardiology Clinics: Cardiac Emergencies.

Birrenkott D, Kabrhel C, Dudzinski D Cardiol Clin. 2024; 42(2):215-235.

PMID: 38631791 PMC: 11154926. DOI: 10.1016/j.ccl.2024.02.008.

Validation of Echocardiographic Measurements in Patients with Pulmonary Embolism in the RIETE Registry.

Lyhne M, Bikdeli B, Dudzinski D, Muriel-Garcia A, Kabrhel C, Sancho-Bueso T TH Open. 2024; 8(1):e1-e8.

PMID: 38197015 PMC: 10774011. DOI: 10.1055/s-0043-1777765.

References

Sarosiek S, Rybin D, Weinberg J, Burke P, Kasotakis G, Sloan J . Association Between Inferior Vena Cava Filter Insertion in Trauma Patients and In-Hospital and Overall Mortality. JAMA Surg. 2016; 152(1):75-81. DOI: 10.1001/jamasurg.2016.3091. View

Kearon C, Akl E, Ornelas J, Blaivas A, Jimenez D, Bounameaux H . Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149(2):315-352. DOI: 10.1016/j.chest.2015.11.026. View

Giri J, Sista A, Weinberg I, Kearon C, Kumbhani D, Desai N . Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(20):e774-e801. DOI: 10.1161/CIR.0000000000000707. View

Pasrija C, Kronfli A, George P, Raithel M, Boulos F, Herr D . Utilization of Veno-Arterial Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism. Ann Thorac Surg. 2017; 105(2):498-504. DOI: 10.1016/j.athoracsur.2017.08.033. View

Corrigan D, Prucnal C, Kabrhel C . Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients. Clin Exp Emerg Med. 2016; 3(3):117-125. PMC: 5065342. DOI: 10.15441/ceem.16.146. View

Marron R, Rali P, Hountras P, Bull T . Inferior Vena Cava Filters: Past, Present, and Future. Chest. 2020; 158(6):2579-2589. DOI: 10.1016/j.chest.2020.08.002. View

Akhtar O, Lakhter V, Zack C, Hussain H, Aggarwal V, Oliveros E . Contemporary Trends and Comparative Outcomes With Adjunctive Inferior Vena Cava Filter Placement in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis in the United States: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2018; 11(14):1390-1397. DOI: 10.1016/j.jcin.2018.04.048. View

Poyiadji N, Cormier P, Patel P, Hadied M, Bhargava P, Khanna K . Acute Pulmonary Embolism and COVID-19. Radiology. 2020; 297(3):E335-E338. PMC: 7706099. DOI: 10.1148/radiol.2020201955. View

Turetz M, Sideris A, Friedman O, Triphathi N, Horowitz J . Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Semin Intervent Radiol. 2018; 35(2):92-98. PMC: 5986574. DOI: 10.1055/s-0038-1642036. View

10.

Jimenez D, Garcia-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P . Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest. 2020; 159(3):1182-1196. PMC: 7670889. DOI: 10.1016/j.chest.2020.11.005. View

11.

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F . Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020; 142(2):184-186. DOI: 10.1161/CIRCULATIONAHA.120.047430. View

12.

Chechi T, Vecchio S, Spaziani G, Giuliani G, Giannotti F, Arcangeli C . Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv. 2009; 73(4):506-13. DOI: 10.1002/ccd.21858. View

13.

Dudzinski D, Giri J, Rosenfield K . Interventional Treatment of Pulmonary Embolism. Circ Cardiovasc Interv. 2017; 10(2). DOI: 10.1161/CIRCINTERVENTIONS.116.004345. View

14.

Rothschild D, Goldstein J, Ciacci J, Bowers T . Ultrasound-accelerated thrombolysis (USAT) versus standard catheter-directed thrombolysis (CDT) for treatment of pulmonary embolism: A retrospective analysis. Vasc Med. 2019; 24(3):234-240. DOI: 10.1177/1358863X19838350. View

15.

Qanadli S, Gudmundsson L, Rotzinger D . Catheter-directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines. Thromb Res. 2020; 192:9-11. PMC: 7205661. DOI: 10.1016/j.thromres.2020.05.007. View

16.

Meneveau N, Guillon B, Planquette B, Piton G, Kimmoun A, Gaide-Chevronnay L . Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J. 2018; 39(47):4196-4204. DOI: 10.1093/eurheartj/ehy464. View

17.

Tu T, Toma C, Tapson V, Adams C, A Jaber W, Silver M . A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study. JACC Cardiovasc Interv. 2019; 12(9):859-869. DOI: 10.1016/j.jcin.2018.12.022. View

18.

Pendower L, Benedetti G, Breen K, Karunanithy N . Catheter-directed thrombolysis to treat acute pulmonary thrombosis in a patient with COVID-19 pneumonia. BMJ Case Rep. 2020; 13(8). PMC: 7418852. DOI: 10.1136/bcr-2020-237046. View

19.

Piazza G, Hohlfelder B, Jaff M, Ouriel K, Engelhardt T, Sterling K . A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015; 8(10):1382-1392. DOI: 10.1016/j.jcin.2015.04.020. View

20.

Alkhouli M, Morad M, Narins C, Raza F, Bashir R . Inferior Vena Cava Thrombosis. JACC Cardiovasc Interv. 2016; 9(7):629-43. DOI: 10.1016/j.jcin.2015.12.268. View